Insulin Aspart Protamine Injection and Omadacycline Tosylate
Determining the interaction of Insulin Aspart Protamine Injection and Omadacycline Tosylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart Protamine Injection-Omalizumab
- Insulin Aspart Protamine Injection-Omalizumab Subcutaneous
- Insulin Aspart Protamine Injection-Ombitasvir, Paritaprevir, and Ritonavir
- Insulin Aspart Protamine Injection-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Insulin Aspart Protamine Injection-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Insulin Aspart Protamine Injection-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Omadacycline Tosylate-Insulin aspart, recombinant Subcutaneous
- Omadacycline Tosylate-Insulin degludec
- Omadacycline Tosylate-Insulin Degludec (U-100) Prefilled Pens
- Omadacycline Tosylate-Insulin Degludec (U-100) Vials
- Omadacycline Tosylate-Insulin Degludec (U-200) Prefilled Pens
- Omadacycline Tosylate-Insulin degludec and liraglutide